Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial
Titel:
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial
Auteur:
Kontro, Mika Stein, Anthony Selwyn Pyörälä, Marja Rimpiläinen, Johanna Siitonen, Timo Ylitalo, Arno Fjällskog, Marie-Louise Jalkanen, Juho Aakko, Sofia Pawlitzky, Inka Hollmén, Maija Daver, Naval